Oral products and first-pass risks

Swallowed THC is absorbed via the gastrointestinal tract and then passes entirely through the liver before reaching the rest of the systemic circulation. There, liver enzymes (primarily CYP2C9 and CYP3A4) convert a significant portion of it into 11-hydroxy-THC (11-OH-THC) - a metabolite that crosses the blood-brain barrier more easily and is considered more psychoactive than THC itself.

How much stronger is a matter of disagreement in the literature - some sources say 2 to 3 times, others up to 5 times. The only responsible statement here is: several times stronger, without pinning down a single exact figure. This is the pharmacological reason why edibles feel different from smoking or vaping - typically more intense, more body-focused, more sedating, and longer-lasting.

The oral bioavailability of THC is low and varies widely - roughly between 4 and 12%. Causes include poor water solubility, partial breakdown in the stomach, and the first-pass effect in the liver. In practice, this means: the same mg amount can have noticeably different effects in different people - and even in the same person on different days, depending on stomach contents.

This is the most important practical point in this article: because onset can take 30 to over 120 minutes, many people - often unconsciously comparing it to the near-instant effect of inhalation - expect a faster response. If 'nothing has happened yet' after 20-30 minutes, the obvious conclusion is 'this isn't working' - and a redose follows before the first dose has even started to take effect.

The result is a significantly higher effective dose than actually intended, often with a time lag - both portions then take effect at roughly the same time and reinforce each other. Across nearly every type of source - clinical, regulatory, community-based - this pattern is the most commonly reported real-world cannabis harm-reduction problem of all.

Monte and colleagues analyzed medical records from a large academic emergency department in Colorado (2012-2016) in the Annals of Internal Medicine in 2019, comparing cannabis-related visits by route of administration. For edibles, acute psychiatric symptoms occurred in 18.0% of cases versus 10.9% for inhaled cannabis; cardiovascular symptoms in 8.0% versus 3.1%; and general intoxication in 48% versus 28%.

Another finding from the same study: edibles accounted for less than 1% of sales by THC content, but were involved in around 11% of cannabis-related emergency department visits - about 33 times what their market share would predict. This is a single, albeit large and peer-reviewed, study from one hospital system - not universal proof, but a clear signal.

Important for context: an acute fatal THC overdose in adults is not documented in the scientific literature. Overconsumption leads to intense but temporary discomfort - panic, anxiety, rapid heartbeat, nausea, or vomiting - which typically resolves within a few hours. Unpleasant and frightening in the moment, but not life-threatening according to current knowledge.